Protein tyrosine phosphatase receptor δ tagged posts

Researchers Identify Potential New Treatment for Metabolic Syndrome

Highlights
Protein tyrosine phosphatase receptor δ is the orexigenic asprosin receptor
Ptprd loss results in appetite reduction and unresponsiveness to exogenous asprosin
AgRP neuron-specific Ptprd ablation leads to protection from diet-induced obesity
The Ptprd ligand-binding domain functions as an appetite-suppressing therapeutic

Metabolic syndrome increases a person’s risk for diabetes, heart disease, and stroke, and includes conditions such as obesity, high blood pressure and high blood sugar...

Read More